Bioventus (BVS) Non-Current Assets (2020 - 2026)

Bioventus (BVS) has 7 years of Non-Current Assets data on file, last reported at $400.7 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 9.35% year-over-year to $400.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (down 10.0% YoY), and the FY2025 full-year result was $410.7 million, down 9.2% from the prior year.
• Non-Current Assets for Q1 2026 stood at $400.7 million, down from $410.7 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $1.1 billion in Q4 2022 and bottomed at $400.7 million in Q1 2026.
• The 5-year median for Non-Current Assets is $528.3 million (2024), against an average of $612.4 million.
• The widest annual swing landed in 2022, when Non-Current Assets soared 175.73%; it then tumbled 50.65% in 2023.
• A 5-year view of Non-Current Assets shows it stood at $1.1 billion in 2022, then sank by 50.65% to $542.9 million in 2023, then dropped by 16.68% to $452.3 million in 2024, then dropped by 9.2% to $410.7 million in 2025, then fell by 2.43% to $400.7 million in 2026.
• The last three Non-Current Assets figures came in at $400.7 million (Q1 2026), $410.7 million (Q4 2025), and $420.7 million (Q3 2025), per Business Quant data.

Peer Comparison